IPCA Laboratories Board ‘of Directors Approves The System Amalgamtion

Ipca Laboratories Board meeting on September 17, 2011 approved the merger of Tonira Pharma company, with effect from April 1, 2011 (being the date) through a scheme of merger.

The plan envisages an exchange ratio of six shares of stock of R 2 each, fully paid capital of 100 shares of Rs 10 IPCA Laboratories each fully paid Tonira Pharma. The exchange ratio is based on the joint evaluation by Natvarlal Vepari & Co., Certified Public Accountants and GM Kapadia & Co., Chartered Accountants.


Comments are closed.